Unum Therapeutics' IPO

Unum Therapeutics raised a round of funding on March 29, 2018. Investors include Public.

Unum Therapeutics is a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many different cancers. Unum develops combination cancer therapies using recent…

Articles about Unum Therapeutics' IPO: